Form 4: Repligen COO Sells Shares Under 10b5-1 Plan

Repligen's Chief Operating Officer, James Bylund, sold 2,191 shares of common stock for approximately $151.21 per share under a pre-arranged plan.

Summary

• James Bylund, Chief Operating Officer of Repligen Corp (RGEN), reported a sale of common stock.
• The transaction involved the disposition of 2,191 shares of common stock.
• The sale occurred on November 18, 2025, at a weighted average price of $151.21 per share.
• The shares were sold in multiple transactions within a price range of $151.21 to $151.62.
• Following the reported transaction, James Bylund beneficially owns 21,520 shares of common stock directly.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 3

Explanation: The filing reports an insider sale of common stock by the COO. While executed under a Rule 10b5-1 plan, insider sales can sometimes be perceived as a neutral to slightly negative signal. The most significant concern is the reported transaction date of November 18, 2025, which is in the future, suggesting a potential clerical error in the filing itself, which impacts the reliability of the reported information.

Negatives

• The filing reports an insider sale of common stock by the Chief Operating Officer, which can sometimes be perceived as a neutral to slightly negative signal by investors.
• The reported transaction date of November 18, 2025, is in the future, suggesting a potential clerical error in the filing itself, which impacts the immediate reliability of the reported information.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This insider transaction report is specific to Repligen Corp and its Chief Operating Officer, James Bylund. It does not provide broader industry trends or competitive analysis.

Related Party Transactions

• The transaction involves an insider (Chief Operating Officer) selling company stock, which is a form of related party transaction.

Stakeholder Impact

• Shareholders may view the insider sale as a neutral to slightly negative signal, although the execution under a Rule 10b5-1 plan often mitigates concerns about the timing of the sale.
• The unusual future transaction date could lead to confusion or questions among stakeholders regarding the accuracy of SEC filings.

Key Dates

Recommendation

The filing details a sale of shares by the Chief Operating Officer under a pre-arranged Rule 10b5-1 plan. Such sales are often for personal financial planning and do not necessarily reflect a change in management's outlook on the company's prospects. However, the reported transaction date of November 18, 2025, is in the future, which is highly unusual and suggests a potential error in the filing. This anomaly makes it difficult to draw definitive conclusions or alter an investment thesis based solely on this document. Investors should await clarification on the transaction date.

Keywords

Repligen, RGEN, Insider Trading, Form 4, Stock Sale, James Bylund, COO, 10b5-1 Plan